通过迪奥辛向BMI1-Noxa轴,诱导口腔状细胞癌细胞的亡
Jinglin Fang1,2, Ruirui Wang3, Xiaoying Li3
1School of Stomatology, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
Journal of Cancer
|January 2, 2025
概括
迪奥辛是一种天然化合物,通过向BMI1-Noxa通路,诱导口腔状细胞癌 (OSCC) 的亡. 这项研究揭示了 Dioscin 的存在.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 自然产品 化学 化学
背景情况:
- 迪奥辛是一种具有已知的抗瘤特性的类固醇氨酸.
- BMI1-Noxa轴与各种癌症有关.
- 口腔状细胞癌 (OSCC) 仍然是一个重大的健康问题.
研究的目的:
- 为了研究OSCC中迪奥辛的抗瘤机制.
- 阐明BMI1-Noxa轴在迪奥辛诱导的亡中的作用.
- 在临床前的OSCC模型中评估迪奥辛的疗效.
主要方法:
- 细胞培养OSCC线的细胞培养.
- 迪奥辛治疗和对亡标志物的评估.
- 西部斑点分析以确定BMI1和Noxa蛋白水平.
- 用于BMI1.1的乌比基化试验.
- 对于Noxa mRNA表达的定量实时PCR.
- 在体内异种移植瘤模型.
主要成果:
- 狄奥治疗提高了OSCC细胞中诺克萨的表达.
- 迪奥辛通过促进其无处不在和降解,损害了BMI1蛋白表达.
- 迪奥辛对诺克萨的上调导致OSCC细胞的亡激活.
- 迪奥辛在异种移植模型中显示出显著的瘤抑制.
结论:
- 狄奥素通过BMI1-Noxa通路有效抑制OSCC细胞的生长.
- 迪奥辛促进BMI1的降解,导致诺克萨的上调和亡.
- 迪奥辛代表了OSCC治疗的潜在治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.6K
12:28Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Published on: January 11, 2019
7.3K
相关概念视频
The Intrinsic Apoptotic Pathway
5.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Inhibition of Cdk Activity
4.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.5K
Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
